EDGAR Filing Documents for 0001654954-24-007669

Form PRE 14A - Other preliminary proxy statements:

SEC Accession No. 0001654954-24-007669

Filing Date

2024-06-12

Accepted

2024-06-12 17:22:01

Documents

Period of Report

2024-06-11

Document Format Files

Seq	Description	Document	Type	Size
1	PRE 14A	ndra_pre14a.htm	PRE 14A	545097
2		ndra_pre14aimg10.jpg	GRAPHIC	3417
3		ndra_pre14aimg11.jpg	GRAPHIC	7302
4		ndra_pre14aimg12.jpg	GRAPHIC	33932
5		ndra_pre14aimg15.jpg	GRAPHIC	162866
6		ndra_pre14aimg16.jpg	GRAPHIC	135597
7		ndra_pre14aimg7.jpg	GRAPHIC	6936
8		ndra_pre14aimg8.jpg	GRAPHIC	1997
9		ndra_pre14aimg9.jpg	GRAPHIC	7299
	Complete submission text file	0001654954-24-007669.txt		1042163

Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105

Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468

ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37969 | Film No.: 241039357
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)